These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27150091)

  • 1. Cholesterol Absorption and Metabolism.
    Howles PN
    Methods Mol Biol; 2016; 1438():177-97. PubMed ID: 27150091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol absorption and metabolism.
    Howles PN
    Methods Mol Biol; 2010; 602():157-79. PubMed ID: 20012398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rHDL administration increases reverse cholesterol transport in mice, but is not additive on top of ezetimibe or cholestyramine treatment.
    Maugeais C; Annema W; Blum D; Mary JL; Tietge UJ
    Atherosclerosis; 2013 Jul; 229(1):94-101. PubMed ID: 23725986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
    Davidson MH; Voogt J; Luchoomun J; Decaris J; Killion S; Boban D; Glass A; Mohammad H; Lu Y; Villegas D; Neese R; Hellerstein M; Neff D; Musliner T; Tomassini JE; Turner S
    Atherosclerosis; 2013 Oct; 230(2):322-9. PubMed ID: 24075764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid lowering activity of drugs affecting cholesterol absorption.
    Norata GD; Catapano AL
    Nutr Metab Cardiovasc Dis; 2004 Feb; 14(1):42-51. PubMed ID: 15053163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on patented cholesterol absorption inhibitors.
    Chhabria MT; Mahajan BM
    Expert Opin Ther Pat; 2009 Aug; 19(8):1083-107. PubMed ID: 19552506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cholesterol homeostasis.
    van der Wulp MY; Verkade HJ; Groen AK
    Mol Cell Endocrinol; 2013 Apr; 368(1-2):1-16. PubMed ID: 22721653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages.
    Sehayek E; Hazen SL
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1296-7. PubMed ID: 18420997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment.
    Altemus JB; Patel SB; Sehayek E
    Metabolism; 2014 Oct; 63(10):1334-41. PubMed ID: 25060694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol and plant sterol absorption: recent insights.
    von Bergmann K; Sudhop T; Lütjohann D
    Am J Cardiol; 2005 Jul; 96(1A):10D-14D. PubMed ID: 15992510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the screening methods of NPC1L1 inhibitors.
    Zhang R; Liu W; Zeng J; Meng J; Shi L; Yang S; Chang J; Wang C; Xing K; Wen J; Liu N; Liang B; Xing D
    Biomed Pharmacother; 2022 Nov; 155():113732. PubMed ID: 36166964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk.
    Weingärtner O; Lütjohann D; Böhm M; Laufs U
    Atherosclerosis; 2010 Jun; 210(2):362-5. PubMed ID: 20116793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol-lowering activity of sesamin is associated with down-regulation on genes of sterol transporters involved in cholesterol absorption.
    Liang YT; Chen J; Jiao R; Peng C; Zuo Y; Lei L; Liu Y; Wang X; Ma KY; Huang Y; Chen ZY
    J Agric Food Chem; 2015 Mar; 63(11):2963-9. PubMed ID: 25745846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects.
    Niesor EJ; Chaput E; Staempfli A; Blum D; Derks M; Kallend D
    Atherosclerosis; 2011 Dec; 219(2):761-7. PubMed ID: 21982411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New treatment option for decreasing blood cholesterol level--clinical significance of inhibition of both, cholesterol absorption and synthesis].
    Paragh G; Márk L; Czine Z
    Orv Hetil; 2004 Apr; 145(15):805-11. PubMed ID: 15188635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?
    Descamps OS; De Sutter J; Guillaume M; Missault L
    Atherosclerosis; 2011 Aug; 217(2):308-21. PubMed ID: 21762916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of plant sterols supplementation in addition to different lipid-lowering regimens.
    Malina DM; Fonseca FA; Barbosa SA; Kasmas SH; Machado VA; França CN; Borges NC; Moreno RA; Izar MC
    J Clin Lipidol; 2015; 9(4):542-52. PubMed ID: 26228672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.